Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ciscure 0.25mg Injection

Prescription Icon
Prescription Required

Marketer

Emcure Pharmaceuticals Ltd

Salt Composition

Cetrorelix (0.25mg)

Overview Ciscure 0.25mg Injection

GnRH antagonist Cetrorelix 0.25mg injection treats female infertility. It suppresses premature egg release, preventing ovulation. Administered subcutaneously by a healthcare professional, self-injection is prohibited. Home injection guidance will be provided by your doctor or nurse. Dosage and frequency vary depending on your condition; your physician determines the optimal treatment plan. Continue using as prescribed. Common side effects include injection site reactions (redness, itching, irritation), nausea, and vomiting. Rotate injection sites daily to minimize irritation. Report dizziness, fainting, abdominal pain, or persistent vomiting immediately. Before starting treatment, inform your doctor of any liver or kidney disease, or breastfeeding. Disclose all other medications you are using, as interactions can affect Cetrorelix's efficacy.

Uses of Ciscure 0.25mg Injection

Inability to conceive in women

Major Benefits of Ciscure 0.25mg Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Ciscure 0.25mg Injection:

  • Nausea
  • Ovarian hyperstimulation syndrome
  • Injection site reactions (pain, swelling, redness)
  • Itching
  • Irritation
  • Vomiting
  • Lower abdominal pain

How to use Ciscure 0.25mg Injection:

The medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Ciscure 0.25mg Injection works:

During infertility treatment in women, the premature discharge of immature, unfertilizable eggs can occur. Ciscures 0.25mg Injection inhibits a naturally occurring hormone, thereby preventing this premature ovarian egg release.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Ciscure 0.25mg Injection concurrently with alcohol. Physician consultation is recommended.

PregnancyPregnancyUNSAFE

Administering Ciscure 0.25mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, given that research in animals and pregnant humans has revealed considerable adverse effects on fetal development.

Breast feedingBreast feedingUNSAFE

Administering Ciscure 0.25mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingSAFE

Administration of Ciscure 0.25mg Injection typically does not impair driving ability.

KidneyKidneyCAUTION

For individuals with kidney impairment, administering Ciscure 0.25mg Injection requires careful consideration and potential dosage modification. Physician consultation is advised. Ciscure 0.25mg Injection is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Ciscure 0.25mg Injection cautiously, as dose modification may be necessary. Physician consultation is advised.

What if you forget to take Ciscure 0.25mg Injection :

Should you forget a Ciscure 0.25mg Injection, seek your physician's advice.

Facts to Know About Ciscure 0.25mg Injection

LabelValue
Chemical Category Peptide chains
Developing Habits No.
Treatment Category Endocrine Signals
Actions GnRH receptor antagonists

FAQs on Ciscure 0.25mg Injection

Ganirelix 0.25mg Injection is an injectable medication used in assisted reproductive technologies for women. By suppressing luteinizing hormone (LH) release, it prevents premature egg release, allowing for optimal egg maturation. This injection is typically administered alongside other fertility medications.
Administered intravenously by a healthcare professional in a hospital or clinic setting, patients receive regular monitoring of follicular development. Treatment length varies based on individual ovarian response.
The most frequent side effect is localized skin redness, possibly with swelling. Headache or nausea may also occur. These effects are usually temporary; however, persistent symptoms warrant a doctor's consultation. Additionally, ovarian hyperstimulation syndrome (OHSS), multiple births, and birth defects are potential, though associated, risks.
Ciscure 0.25mg Injection
1,528
MRP 1,862
17% off